Efficacy of a combined drug containing ferrous fumarate and folic acid in anemia in the second trimester of pregnancy: results of a multicenter study

Pavlovich S.V., Melikhov O.G., Khodzhaeva Z.S., Muminova K.T., Sakalo V.A., Gorodnova E.A., Abashova E.I., Yarmolinskaya M.I., Chulkov V.S., Nazipova Z.M., Savelyeva I.V., Andreeva M.D., Kudlai Yu.V., Enkova E.V., Zaripova A.Sh.

1) Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia; 2) Scientific Society “League for Promoting Clinical Trials”, Moscow, Russia; 3) Institute of Clinical Research, Moscow, Russia; 4) D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology, Saint Petersburg, Russia; 5) City Center for Hemostatic Pathology, Chelyabinsk, Russia; 6) Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, Kazan, Russia; 7) Omsk State Medical University, Ministry of Health of Russia, Omsk, Russia; 8) Kuban State Medical University, Ministry of Health of Russia, Krasnodar, Russia; 9) Voronezh City Clinical Polyclinic No. 1, Voronezh, Russia; 10) Nurmed Medical Center, Kazan, Russia
Objective: To evaluate the effect of ferrous fumarate/folic acid (FF/FA) on the clinical and laboratory signs of anemia in pregnant women in the second trimester. Materials and methods: The investigation enrolled 160 women at 14 to 20 weeks’ gestation who were diagnosed with anemia and were prescribed FF/FA. Results: The use of FF/FA caused a significant improvement in clinical and biochemical blood test results reflecting the severity of anemia: an increase in Hb, Ht, RBC, MCV, MCH, MCHC, serum iron, and ferritin, a decrease in the frequency of microcytosis and serum latent iron-binding capacity. After 3 months of therapy, the total study population displayed an increase in mean values of HgB from 102.0 to 117.0 g/l, ferritin from 46.2 to 55.9 µg/l, serum iron from 12.02 to 20.49 µmol/l. The proportion of patients without anemia was 77% (118/153); that with mild and moderate anemia were 20% (31/153), and 2% (3/153), respectively, which shows a significant improvement compared to that at the start of therapy. In the group with iron deficiency anemia (IDA), (Hb<110 g/l, ferritin<30 µg/l), Hb increased from an average of 103.3 to 109.8 g/l, ferritin from 14.4 to 24.3 µg/l, serum iron from 11.87 to 20.53 µmol/l. After 3 months, mild and moderate IDA was present in 30% (28/93) and 3% (3/93) patients, respectively. Conclusion. The findings are comparable with international and Russian data and can conclude that FF/FA is an effective and safe way to correct IDA in pregnant women and is suitable for long-term use. Authors’ contributions: Pavlovich S.V., Melikhov O.G. – development of the concept and design of the investigation, writing the text; Pavlovich S.V., Abashova E.I., Chulkov V.S., Nazipova Z.M., Savelyeva I.V., Andreeva M.D., Kudlai Yu.V., Enkova E.V., Khodzhaeva Z.S., Muminova K.T., Sakalo V.A., Gorodnova E.A., Zaripova A.Sh., Melikhov O.G. – material collection and processing, editing; Melikhov O.G. – statistical data processing; Melikhov O.G., Pavlovich S.V. – analysis of literature data. Conflicts of interest: The authors declare that there are no conflicts of interest. Fundind: This investigation has not been sponsored by Acino Rus Co. Patient Consent for Publication: The patients have signed an informed consent form to their participation in the investigation and to the publication of their data. Authors' Data Sharing Statement: The data supporting the conclusions of this investigation are available upon request from the corresponding author after approval by the research supervisor of the project. For citation: Pavlovich S.V., Melikhov O.G., Khodzhaeva Z.S., Muminova K.T., Sakalo V.A., Gorodnova E.A., Abashova E.I., Yarmolinskaya M.I., Chulkov V.S., Nazipova Z.M., Savelyeva I.V., Andreeva M.D., Kudlai Yu.V., Enkova E.V., Zaripova A.Sh. Efficacy of a combined drug containing ferrous fumarate and folic acid in anemia in the second trimester of pregnancy: results of a multicenter study. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2023; 2: 108-116 (in Russian) https://dx.doi.org/10.18565/aig.2023.51

Keywords

anemia
iron deficiency anemia
iron preparations
folic acid
pregnancy
second trimester
hemoglobin
ferritin

References

  1. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization; 2011. Available at: https://apps.who.int/iris/handle/10665/85839]
  2. Министерство здравоохранения Российской Федерации. Железодефицитная анемия. Клинические рекомендации. М.; 2021. [Ministry of Health of the Russian Federation. Iron deficiency anemia. Clinical guidelines. Мoscow; 2021. (in Russian)].
  3. Pavord S., Daru J., Prasannan N., Robinson S., Stanworth S., Girling J.; BBSH Committee. UK guidelines on the management of iron deficiency in pregnancy. Br. J. Haematol. 2020; 188(6): 819-30. https://dx.doi.org/10.1111/bjh.16221.
  4. WHO. WHO Global Anaemia estimates, 2021 Edition. WHO Global health observatory. 2022. Available at: https:// www.who.int/data/gho/data/themes/topics/anaemia_in_women_and_children
  5. Jung J., Rahman M.M., Rahman M.S., Swe K.T., Islam M.R., Rahman M.O., Akter S. Effects of hemoglobin levels during pregnancy on adverse maternal and infant outcomes: a systematic review and meta-analysis. Ann. N. Y. Acad. Sci. 2019; 1450: 69-82. https://dx.doi.org/10.1111/nyas.14112.
  6. Masukume G., Khashan A.S., Kenny L.C., Baker P.N., Nelson G. SCOPE Consortium. Risk factors and birth outcomes of anaemia in early pregnancy in a nulliparous cohort. PLoS One. 2015; 10(4): e0122729. 10.1371/journal.pone.0122729.
  7. Christian P., Mullany L.C., Hurley K.M., Katz J., Black R.E. Nutrition and maternal, neonatal, and child health. Semin. Perinatol. 2015; 39(5): 361-72. https://dx.doi.org/10.1053/j.semperi.2015.06.009.
  8. Резолюция Совета экспертов по профилактике и лечению железодефицитной анемии у беременных. Акушерство и гинекология. 2020; 4: 230-2. [Expert council resolution on prevention and treatment of iron deficiency anemia in pregnant women. Obstetrics and Gynecology. 2020; (4): 230-2. https://dx.doi.org/10.18565/aig.2020.4.230-232.
  9. Всемирная организация здравоохранения. Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительногоопыта беременности. 2017. 196с. Доступно по ссылке: https://www.who.int/ru/publications/i/item/9789241549912. [WHO. WHO guidelines on prenatal care for a positive pregnancy experience. 2017. 196p. Available at: https://www.who.int/ru/publications/i/item/9789241549912 (in Russian)].
  10. Wang L., Mei Z., Li H., Zhang Y., Liu J., Serdula M.K. Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial. Br. J. Nutr. 2016; 115(4): 644-9. https://dx.doi.org/10.1017/S0007114515004870.
  11. Коротких И.Н., Литвиненко О.В. Железодефицитные состояния беременных и их медикаментозная коррекция. РМЖ. Мать и дитя. 2019; 2(4): 292-5. [Korotkikh I.N., Litvinenko O.V. Iron deficiencies in pregnancy and their pharmacotherapy. Russian Journal of Woman and Child Health. 2019; 2(4): 292-5. (in Russian)]. https://dx.doi.org/10.32364/2618-8430-2019-2-4-292-295.
  12. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Гоголева И.В. Систематический анализ фармакологических свойств протеин сукцинилата железа. Эффективная фармакотерапия. 2018; 13: 20-9. [Gromova O.A., Torshin I.Yu., Tetruashvili N.K., Gogoleva I.V. Systematic analysis of ferrous protein succinilate pharmacological properties. Effective Pharmacotherapy. 2018; (13): 20-9. (in Russian)].
  13. Wahyuwibowo J., Aziz A., Safitri E., Minidian F., Zulaikhah S.T. Iron-folate supplementation during pregnancy for prevent oxidative stress in pregnant rats: Level of MDA, Creatinine, Glucose, Erythrocite, Blood Pressure, Body Weight and Number of Offspring. Pharmacog. J. 2020; 12(1): 186-91.https://dx.doi.org/10.5530/pj.2020.12.28.
  14. Cawley S., Mullaney L., McKeating A., Farren M., McCartney D., Turner M.J. An analysis of folic acid supplementation in women presenting for antenatal care. J. Public Health (Oxf.). 2016; 38(1): 122-9. https://dx.doi.org/10.1093/pubmed/fdv019.
  15. Stamm R.A., Houghton L.A. Nutrient intake values for folate during pregnancy and lactation vary widely around the world. Nutrients. 2013; 5(10): 3920-47. https://dx.doi.org/10.3390/nu5103920.
  16. Roche M.L., Samson K.L.I., Green T.J., Karakochuk C.D., Martinez H.Perspective: weekly iron and folic acid supplementation (WIFAS):a critical review and rationale for inclusion in the essential medicines list to accelerate anemia and neural tube defects reduction. Adv. Nutr. 2021; 12(2): 334-42. https://dx.doi.org/10.1093/advances/nmaa169.
  17. O'Malley E.G., Cawley S., Kennedy R.A.K., Reynolds C.M.E., Molloy A., Turner M.J. Maternal anaemia and folate intake in early pregnancy. J. Public Health (Oxf.). 2018; 40(3): e296-e302. https://dx.doi.org/10.1093/pubmed/fdy013.
  18. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Павлович С.В. Систематический анализ молекулярного синергизма фолиевой кислоты и фумарата железа при железодефицитной анемии. Акушерство и гинекология. 2022; 12: 178-86. [Gromova O.A., Torshin I.Yu., Tetruashvili N.K., Pavlovich S.V. Systematic analysis of molecular synergy between folic acid and ferrous fumarate in iron deficiency anemia. Obstetrics and Gynecology. 2022; (12): 178-86. (in Russian)]. https://dx.doi.org/10.18565/aig.2022.301.
  19. Giblin T.J. Jr, Lee J.F., Rattigan J.P. Ferrous fumarate: a well-tolerated oral iron preparation. Clin. Med. (Northfield). 1962; 69: 2258-60.
  20. Yismaw A.E., Tulu H.B., Kassie F.Y., Araya B.M. Iron-folic acid adherence and associated factors among pregnant women attending antenatal care at Metema District, Northwest Ethiopia. Front. Public Health. 2022; 10: 978084.https://dx.doi.org/10.3389/fpubh.2022.978084.
  21. Кирилюк А.А. Железосодержащие лекарственные средства: от клинической фармакологии до фармацевтической помощи (сообщение 1). Вестник фармации. 2020; 3: 81-97. [Kirilyuk A.A. Iron-containing medicines: from clinical pharmacology to pharmaceutical assistance (report 1). Bulletin of Pharmacy. 2020; (3): 81-97. (in Russian)].
  22. Торшин И.Ю., Громова О.А., Лиманова О.А., Гришина Т.Р.,Башмакова Н.В., Керимкулова Н.В., Серова О.Ф., Крапошина Т.П.,Косенко И.М. Метаанализ клинических исследований по применению фумарата железа с целью профилактики и терапии железодефицитной анемии у беременных. Гинекология. 2015; 17(5): 24-31.[Torshin I.Iu., Gromova O.A., Limanova O.A., Grishina T.R., Bashmakova N.V., Kerimkulova N.V., Serova O.F., Kraposhina T.P., Kosenko I.M. A meta-analysis of clinical studies on the use of iron fumarate for the prevention and treatment of iron deficiency anemia in pregnantwomen. Gynecology. 2015; 17(5): 24-31. (in Russian)].
  23. Хельсинкская декларация Всемирной медицинской ассоциации. Принята на 18-й Генеральной Ассамблее ВМА, Хельсинки, Финляндия, июнь 1964 г., изменения внесены на 64-й Генеральной Ассамблее ВМА, Форталеза, Бразилия, октябрь 2013 г. [Declaration of Helsinki of the World Medical Association. Adopted at the 18th WMA General Assembly, Helsinki, Finland, June 1964, amended at the 64th WMA General Assembly, Fortaleza, Brazil, October 2013. (in Russian)].
  24. Национальный стандарт Российской Федерации ГОСТ Р 52379-2005 «Надлежащая клиническая практика». [National Standard of the Russian Federation GOST R 52379-2005 "Good Clinical Practice".(in Russian)].
  25. Российское общество акушеров-гинекологов, ФГБУ «Научный Центр акушерства, гинекологии и перинатологии им. В.И. Кулакова». Федеральные клинические рекомендации Минздрава России. Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц. 2013. 26с. [Russian Society of Obstetricians and Gynecologists, V.I. Kulakov Scientific Center for Obstetrics, Gynecology and Perinatology. Federal Clinical Guidelines of the Ministry of Health of Russia. Diagnosis, prevention and treatment of iron deficiency conditions in pregnant and postpartum women. 2013. 26p. (in Russian)].
  26. Mehta B.C. Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia. J. Assoc. Physicians India. 2003; 51: 419-21.
  27. Ruiz-Argüelles G.J., Díaz-Hernández A., Manzano C., Ruiz-Delgado G.J. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia. Hematology. 2007; 12(3): 255-6.https://dx.doi.org/10.1080/10245330701214160.
  28. Gilgen D., Mascie-Taylor C.G. The effect of weekly iron supplementation on anaemia and on iron deficiency among female tea pluckers in Bangladesh. J. Hum. Nutr. Diet. 2001; 14(3): 185-90. https://dx.doi.org/10.1046/j.1365-277x.2001.00291.x.
  29. Баев О.Р. Профилактика и лечение железодефицитных состояний во время беременности: применение комбинации железа и фолиевой кислоты. Фарматека. 2011; 13: 47-52. [Baev O.R. Prevention and treatment of iron deficiency conditions during pregnancy: use of combination of iron and folic acid. Pharmateca. 2011; (13): 47-52. (in Russian)].

Received 20.02.2023

Accepted 27.02.2023

About the Authors

Stanislav V. Pavlovich, PhD, Academic Secretary, Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia; Professor, Department of Obstetrics, Gynecology, Perinatology and Reproductology, I.M. Sechenov First MSMU, Ministry of Health of Russia (Sechenov University), +7(495)438-20-88, s_pavlovich@oparina4.ru,
https://orcid.org/0000-0002-1313-7079, 117997, Russia, Moscow, Akademika Oparina str., 4.
Oleg G. Melikhov, PhD, Director, Institute of Clinical Research; Chairman, Scientific Society “League of Clinical Research”, +7(916)695-05-30, melikhov.oleg@gmail.com, https://orcid.org/0000-0001-9442-7707, 119590, Russia, Moscow, Ulof Palme str., 1.
Zulfiya S. Khodzhaeva, Dr. Med. Sci., Professor, Deputy Director of Obstetrics Institute, Professor at the Department of Obstetrics, Gynecology, Perinatology of the Department of Professional Education, Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia, +7(495)438-07-88, zkhodjaeva@mail.ru,
https://orcid.org/0000-0001-8159-3714, 117997, Russia, Moscow, Ac. Oparina str., 4.
Kamilla T. Muminova, PhD, Researcher at the High Risk Pregnancy Department, Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia, +7(495)438-06-74, kamika91@mail.ru, https://orcid.org/0000-0003-2708-4366, 117997, Russia, Moscow, Ac. Oparina str., 4.
Viktoriya A. Sakalo, PhD, Junior Researcher at the Department of Pregnancy Pathology, Institute of Obstetrics, doctor at the 1st Obstetric Department of Pregnancy Pathology, Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russiaa, +7(929)588-72-08, v_sakalo@oparina4.ru, https://orcid.org/0000-0002-5870-4655, 117997, Russia, Moscow, Ac. Oparina str., 4.
Elena A. Gorodnova, PhD, MPH (Master of Public Health), Head of Scientific & Clinical Center, Academician V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia, +7(495)531-44-44, e_gorodnova@oparina4.ru, Author ID Scopus 6508176604, Author ID 597062, https://orcid.org/0000-0003-39937629,
117997, Russia, Moscow, Ac. Oparina str., 4.
Elena I. Abashova, PhD, Senior Researcher, Department of Gynecology and Endocrinology, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, +7(812)328-98-20, +7(921)945-90-90, abashova@yandex.ru, https://orcid.org/0000-0003-2399-3108, SPIN-код: 2133-0310,
199034, Russia, St. Petersburg, Mendeleevskaya line, 3.
Maria I. Yarmolinskaya, Professor of RAS, Dr. Med. Sci., Professor, Head of the Department of Gynecology and Endocrinology, Head of Center “Diagnostics and treatment of endometriosis”, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology; Professor at the Department of Obstetrics and Gynecology, I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia, m.yarmolinskaya@gmail.com, https://orcid.org/0000-0002-6551-4147, eLibrary SPIN-код: 3686-3605,
199034, Russia, St. Petersburg, Mendeleevskaya line, 3.
Vasilii S. Chulkov, Dr. Med. Sci., Professor at the Department of Faculty Therapy, South-Ural State Medical University, Ministry of Health of Russia, vschulkov@rambler.ru,
https://orcid.org/0000-0002-0952-6856, 454092, Russia, Chelyabinsk, Vorovskogo str., 64.
Zulfira M. Nazipova, hematologist, Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, +7(905)376-21-36, zulfira93@mail.ru,
https://orcid.org/0009-0002-3591-522Х, 420064, Russia, Republic of Tatarstan, Kazan, Orenburgsky Trakt str., 138.
Irina V. Savelyeva, Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology No. 1, Omsk State Medical University, Ministry of Health of Russia, +7(913)654-35-77, saveljeva_iv_omsk@mail.ru, https://orcid.org/0000-0001-9342-7342, 644099, Russia, Omsk, Lenina str., 12.
Margarita D. Andreeva, Dr. Med. Sci., Associate Professor, Professor at the Department of Obstetrics, Gynecology and Perinatology, Faculty of Postgraduate Education, Kuban State Medical University, Ministry of Health of Russia, andreeva_md@mail.ru, https://orcid.org/0000-0002-6524-3965, 350063, Russia, Krasnodar, M. Sedina str., 4.
Yulia V. Kudlai, student of the Faculty of Pediatrics, Kuban State Medical University, Ministry of Health of Russia, +7(988)188-78-92, kudlai.j@yandex.ru,
https://orcid.org/0000-0002-3192-7170, 350063, Russia, Krasnodar, M. Sedina str., 4.
Elena V. Enkova, Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynecology No. 2, N.N. Burdenko Voronezh State Medical University,
Ministry of Health of Russia, enkova@bk.ru, https://orcid.org/0000-0001-8885-1587, 394036, Russia, Voronezh, Studentskaya str., 10.
Aliya Sh. Zaripova, postgraduate student of the Department of Obstetrics and Gynecology named after V.S. Gruzdev, Kazan State Medical University,
Ministry of Health of Russia; Chief Physician of MC "Nurmed", obstetrician-gynecologist, ultrasound diagnostics doctor, +7(917)250-50-70, zaripovaash@yandex.ru,
https://orcid.org/0000-0002-2701-319X, 420012, Russia, Kazan, Butlerov str., 49.
Corresponding author: Oleg G. Melikhov, melikhov.oleg@gmail.com

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.